Current NDC auxiliary source row compounder:3871

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 85933-005
Product Ndc: 85933-005
Product Ndc Digits: 85933005
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: NAD .Plus symbol.
Proprietary Name Suffix: [empty]
Nonproprietary Name: B-Nicotinamide adenine dinucleotide 100 mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Wesley Pharmaceuticals
Establishment Name: Wesley Pharmaceuticals
Establishment Fei: [empty]
Substance Name: NICOTINAMIDE ADENINE DINUCLEOTIDE
Active Ingredients Info: 100 mg/1 mL
History Active Ingredients Raw: NICOTINAMIDE ADENINE DINUCLEOTIDE
History Active Ingredients Info Raw: 100 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 85933-005-10
Package Ndc: 85933-005-10
Package Ndc Digits: 8593300510
Package Ndc11: 85933000510
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (85933-005-10)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3871
Source Row Number: 3871
Source Row Hash: 10326f65238e3f25777bc389b37eb301f77210206963f41bd6dcbebcfaa04cd5
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
    "PRODUCTNDC": "85933-005",
    "DEASCHEDULE": "",
    "LABELERNAME": "Wesley Pharmaceuticals",
    "SUBSTANCENAME": "NICOTINAMIDE ADENINE DINUCLEOTIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "85933-005-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "NAD .Plus symbol.",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "B-Nicotinamide adenine dinucleotide 100 mg/mL",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL, MULTI-DOSE (85933-005-10) ",
    "ACTIVEINGREDIENTSINFO": "100 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3871
Source Row Number: 3871
Status Scope: package
Lookup Ndc: 85933-005-10
Lookup Ndc Digits: 8593300510
Product Ndc: 85933-005
Product Ndc Digits: 85933005
Package Ndc: 85933-005-10
Package Ndc Digits: 8593300510
Package Ndc11: 85933000510
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 10326f65238e3f25777bc389b37eb301f77210206963f41bd6dcbebcfaa04cd5
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27